Not applicableNot Yet RecruitingNCT07285408What this trial is testingSarcopenia and NMIBC Prognosis StudyWho this might be right forBladder Cancer Cell Transitional General Hospital Sveti Duh 150
Early research (Phase 1)WithdrawnNCT03430687What this trial is testingTalimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell CarcinomaWho this might be right forStage 0 Bladder Urothelial Carcinoma AJCC v6 and v7Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7+1 more University of California, San Francisco
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07332351What this trial is testingNeoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA TrialWho this might be right forMuscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8 University of Washington 33
Testing effectiveness (Phase 2)Study completedNCT04602078What this trial is testingStudy of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial CarcinomaWho this might be right forLocally Advanced or Metastatic Urothelial Carcinoma Spanish Oncology Genito-Urinary Group 82
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07189793What this trial is testingToripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 StudyWho this might be right forUrinary Bladder NeoplasmsCarcinoma, Transitional CellCarcinoma in Situ of Bladder+1 more First Affiliated Hospital of Wenzhou Medical University 106
Testing effectiveness (Phase 2)Study completedNCT00002914What this trial is testingPiritrexim in Treating Patients With Advanced Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Eastern Cooperative Oncology Group 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03854474What this trial is testingTesting the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial CarcinomaWho this might be right forLocally Advanced Urothelial CarcinomaMetastatic Urothelial CarcinomaStage III Bladder Cancer AJCC v8+1 more National Cancer Institute (NCI) 30
Not applicableLooking for participantsNCT06991868What this trial is testingProspective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)Who this might be right forNMIBCMIBCUTUC Peking University First Hospital 300
Testing effectiveness (Phase 2)Study completedNCT04701918What this trial is testingCryoablation With Pembrolizumab Or Avelumab In Urothelial CarcinomaWho this might be right forMetastatic Urothelial CarcinomaBladder Cancer Massachusetts General Hospital 9
Testing effectiveness (Phase 2)Study completedNCT00585689What this trial is testingNeoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder CancerWho this might be right forBladder Cancer University of Michigan Rogel Cancer Center 29
Testing effectiveness (Phase 2)Looking for participantsNCT07019220What this trial is testingChemoablation for Low-Grade Bladder CancerWho this might be right forBladder (Urothelial, Transitional Cell) Cancer Ekaterina Laukhtina 47
Early research (Phase 1)Study completedNCT02300610What this trial is testingEnzalutamide in Combination With Gemcitabine and Cisplatin in Bladder CancerWho this might be right forBladder CancerCarcinoma, Transitional CellRenal Pelvis Cancer+2 more H. Lee Moffitt Cancer Center and Research Institute 10
Not applicableStudy completedNCT01846520What this trial is testingFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersWho this might be right forHealthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more City of Hope Medical Center 200
Testing effectiveness (Phase 2)Ended earlyNCT00003642What this trial is testingRadiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder CancerWho this might be right forBladder Cancer European Organisation for Research and Treatment of Cancer - EORTC 43
Testing effectiveness (Phase 2)Ended earlyNCT04039867What this trial is testingEvaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder CancerWho this might be right forCarcinoma, Transitional Cell University of California, Irvine 17
Not applicableStudy completedNCT04314245What this trial is testingDiagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial CarcinomaWho this might be right forUrothelial CarcinomaBladder Cancer AnchorDx Medical Co., Ltd. 1,170
Large-scale testing (Phase 3)Looking for participantsNCT04574960What this trial is testingNeoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)Who this might be right forBladder CancerBladder Urothelial Carcinoma University Health Network, Toronto 14
Not applicableStudy completedNCT06020807What this trial is testingAnalytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder CancerWho this might be right forNon Muscle Invasive Bladder CancerNon-Muscle Invasive Bladder Urothelial Carcinoma Nucleix Ltd. 168
Testing effectiveness (Phase 2)Ended earlyNCT01093066What this trial is testingProspective Multicentric Evaluation of a Bladder Preservation StrategyWho this might be right forUrothelial Carcinoma Centre Hospitalier Universitaire de Saint Etienne 77
Testing effectiveness (Phase 2)Study completedNCT02365766What this trial is testingNeoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC SubjectsWho this might be right forUrothelial CarcinomaBladder Cancer Jason R. Brown 83